/
/
/

Asston Pharmaceuticals Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%

Share Price Live Stats

Open (₹)101.99
Volume (₹)24,000.00
High (₹)102.41
Upper Circuit102.41
Low (₹)99.50
Lower Circuit92.67
Prev Close97.54
52W High (₹)126.10
Price102.41
52W Low (₹)60.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)106.54 Cr
Div. Yield (%)0.00
PE Ratio27.57
Debt to Equity0.68
Price to Book0.00
Book Value17.09
EPS (TTM)3.54
Face Value10.00
ROE (%)50.56

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
ZYDUSLIFE-ANSE
LAURUSLABS-ANSE
CIPLA-ANSE
DRREDDY-ANSE
MANKIND-ANSE
AUROPHARMA-ANSE
LUPIN-ANSE
APL-MTNSE
LTP
1W Low
1W High
Market cap (₹)
1760.6+3.7 (0.21%)
1725.70
1777.40
4,19,620Cr
9039.95-286.05 (-3.07%)
8938
9450
2,39,714Cr
4596-64 (-1.37%)
4554.55
4680.30
1,74,741Cr
1140.75+25.65 (2.30%)
1108
1150.90
1,12,119Cr
2020-12.1 (-0.60%)
2008
2071
1,10,008Cr
1333.7+30.4 (2.33%)
1300.25
1336.65
1,06,061Cr
1220.75+25.65 (2.15%)
1195.65
1250.95
1,01,339Cr
2354.8-14.2 (-0.60%)
2317.80
2425.05
96,244Cr
1675-11.1 (-0.66%)
1645
1714.90
95,590Cr
1959.2-0.8 (-0.04%)
1925.85
1990
89,391Cr
102.41+7.66 (8.08%)
90.25
102.41
107Cr

Key Highlights of Asston Pharmaceuticals Ltd’s P&L

In 2025-03-31, Asston Pharmaceuticals Ltd reported total revenue of ₹25.04Cr, compared with ₹15.59Cr in 2024-03-31, reflecting Asston Pharmaceuticals Ltd turnover.

Depreciation was ₹8.1Lakh and finance costs were ₹94.97Lakh in 2025-03-31

Profit Before Tax (PBT) has been ₹5.7Cr in 2025-03-31 as compared to ₹1.82Cr in 2024-03-31.

Net Profit (PAT) was ₹4.33Cr in 2025-03-31 compared with ₹1.36Cr in 2024-03-31.

Earnings per share (EPS) were ₹6.90 in 2025-03-31, compared with ₹17.35 in 2024-03-31.